Where does Caldera Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Caldera Medical, Inc. ranks #22,330 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Caldera Medical, Inc. hold?

Caldera Medical, Inc. holds 12 US utility patents granted between 2015 and 2025, spanning 5 technology areas.

What is Caldera Medical, Inc.'s Innovation Score?

Caldera Medical, Inc. has an Innovation Score of 32.5 out of 100 (41st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Caldera Medical, Inc. focus on?

Caldera Medical, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 7 patents, ranking #2,341 of 7,127 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Caldera Medical, Inc.'s patent grant rate increasing or decreasing?

Caldera Medical, Inc.'s recent grant velocity is +75% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Caldera Medical, Inc.'s patents?

Caldera Medical, Inc.'s patents average 11.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Caldera Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Caldera Medical, Inc.

USPTO PatentsView assignee record - 12 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Caldera ranks #22,330 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 5 technology areas.

#22,330
of 49,997 US assignees by volume: 41st percentile
by Innovation Score (32.5/100): 11.4
avg claims per patent: +75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22330 · US Corporation #22,330 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,330/49,997
PHOTO-FINISH California Cooperati…
CPC-NARROW A61B · 5 areas
INNOV-THIN 32.5/100
CLAIMS-PAR 11.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: California Cooperative Rice Research Foundation, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Caldera’s 32.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (27%) Velocity 8.9 pts (27%) Breadth 7.9 pts (24%) Claim depth 6.9 pts (21%)

Qualcomm Incorporated · highest

85
Caldera Medical · this assignee

33
3D Lighting… · lowest

7

What this shows Caldera's Innovation Score is 32.5/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Caldera?

Each dot is one of Caldera’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Caldera’s own 11.4 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Caldera vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Caldera's grants concentrate

Caldera Medical, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 58.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2017. By volume, Caldera sits between Crystal International (GROUP), Inc. and Cardea Bio, Inc..

Caldera's three-year grant acceleration

Caldera Medical, Inc. shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Crystal Internati…

12
CSI Cells

12
CU Aerospace

12
Culligan Internat…

12
California Cooper…

12
Canary Medical Sw…

12
Carmax Enterprise…

12
Cardea Bio

12
Caldera Medical ◀

12

What this shows Caldera holds 12 patents at rank #22,382, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Caldera

By rank, the assignees closest to #22,382 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Caldera's primary technology class.

Caldera's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 41st percentile higher than 41% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Caldera Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	16.7%
2017	1	8.3%
2018	1	8.3%
2021	3	25.0%
2022	1	8.3%
2024	3	25.0%
2025partial year	1	8.3%

Which technologies does Caldera Medical, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 7

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 7

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Caldera Medical, Inc.'s patent record in context - here's where to go next.

Caldera Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 58.3% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #22,330 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Caldera Medical, Inc. against Crystal International (GROUP), Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.